To protect the devices, products, and systems that connect patients to healthcare professionals and institutions, we take a broad and deep approach to ensuring safety and security. Our cybersecurity program is built on four pillars. Because technology and threats continue to evolve, we are constantly evaluating and adapting security measures with the goal of ensuring our patients receive the highest quality care. Read more about Our Commitment to Cybersecurity.


Abbott believes that proper nutrition is the foundation for living the best life possible. We aim to make every stage of life a healthy one – and we share this goal with many others around the world. That's why our nutrition business is dedicated to developing science-based nutrition products for people of all ages. We believe that breast milk is the best source of nutrition for infants and support the World Health Organization's goal of increasing breastfeeding rates. Read more about Abbott Infant Formula Marketing.


Abbott believes in the dignity of every human being and respects individual rights as set forth in the United Nations' Universal Declaration of Human Rights and Guiding Principles on Business and Human Rights. While governments have the primary responsibility for respecting, protecting, promoting and fulfilling the human rights of their citizens, Abbott recognizes that companies play a supporting role in promoting human rights within their spheres of influence. We contribute to the fulfillment of human rights through compliance with laws and regulations wherever we operate, as well as through our policies and programs. Read more about our position statement.


Abbott is an active participant in the global dialogue on health and well-being. We recognize that listening to our stakeholders and responding thoughtfully to their concerns and ideas are vital to our success as a business, and to our progress as a global corporate citizen. Understanding stakeholder insights helps us to develop new products to address unmet health needs; educate patients; engage healthcare professionals; and understand how and where our company can make a real difference. Read more about our policy.


Abbott is committed to responsible tax management and transparency across our global operations. With businesses operating in more than 150 countries, our tax contribution is substantial and similarly global in scope, and includes corporate, sales, customs and employee taxes that make a significant contribution to societies around the world. Read more about our position statement.


Consumers trust Abbott products to help them live their best possible lives through better health. We do not take this responsibility lightly. We are fully committed to delivering products with the highest standards of quality, safety and performance. Our quality culture is embedded in everything we do. As part of our efforts to remain up to date with product quality and safety developments, we monitor evolving regulatory requirements and industry practices through our involvement in trade associations, patient groups and other organizations. Read more about our partnerships.


A growing number of laws in the United States require greater transparency in the relationships between our industry and individuals and entities involved in providing healthcare. These laws impose various combinations of code of conduct restrictions on activities involving healthcare professionals and healthcare organizations and tracking and reporting of payments and transfers of value provided. Abbott policies require compliance with all such applicable laws, including the federal Sunshine Act as well as state laws in California, Connecticut, Massachusetts, Nevada, and Vermont.


International Transfers. By using this site, you consent to the collection, storage, and processing of your information in the United States and in any country to which we may transfer your information in the course of our business operations. Where required, Abbott Laboratories has implemented appropriate cross-border transfer solutions to provide adequate protection for transfers of certain personal information, including, but not limited to, the European Commission’s Standard Contractual Clauses.


Abbott is committed to safe and fair working conditions, for our employees and also extending to the partners in our supply chain. Abbott’s Supplier Guidelines require suppliers in a business relationship with Abbott to comply with all legal and regulatory requirements pertaining to human rights and labor practices and prohibit forced, bonded, or indentured labor, prison labor or human trafficking in supply chains. Abbott requires direct suppliers to represent that materials incorporated into Abbott’s products comply with applicable local and national laws of the country or countries in which they are doing business. Abbott engages in verification through assessment and audit of product supply chains to evaluate and address risks of human trafficking and slavery. We maintain a supplier assessment process to monitor compliance with our Supplier Guidelines, where strategic suppliers are assessed to identify potential risks, including those related to human rights. Specifically, Abbott utilizes a risk-based approach to supplier screening, assessment, and monitoring, considering supplier size, industry, sourcing location(s), ESG performance and Abbott spend. Select suppliers may receive a desktop assessment or an on-site audit based on this model. Information received from the supplier is then assessed to determine whether further engagement or action with the supplier is needed. Currently, this verification is conducted by Abbott employees in its Global Purchasing department.

Abbott’s internal Code of Business Conduct (“Code”) reflects our commitment to take steps preventing and prohibiting illegal and inappropriate labor conditions, and cruel or inhumane treatment. Abbott maintains internal accountability standards and procedures related to our Code. Abbott employees worldwide train annually on and certify to Abbott’s Code on a regular basis. Likewise, all contractors assigned to Abbott are expected to abide by the principles of Abbott’s Code. Any employee violating our Code, policies or procedures is subject to appropriate disciplinary action, which may include termination.


Following approval of a drug or biologic product, the U.S. Food and Drug Administration (FDA) may request and/or require the sponsoring company to conduct further studies that are designed to gather additional information about a product’s safety, effectiveness, and/or optimal use. These postmarketing commitment (PMC) studies build upon the data that was submitted for approval.

This website contains Abbott’s U.S. postmarketing commitments. Click here to view Abbott’s PMC Summary Table.

Our PMC Summary Table includes all active postmarketing commitments and provides the following information, organized alphabetically by product name:

  • Name of Product
  • NDA/BLA Number
  • Description of Commitment
  • Date Commitment Given
  • FDA Projected Completion Date
  • Commitment Status

Please note that the status and/or number of Abbott’s postmarketing commitments shown on the FDA website may differ from the information displayed on this site based on the timing of content review and website updates. The status categories used in the PMC Summary Table are consistent with categories used by the FDA.

Information about Abbott’s PMCs will be updated twice a year, to reflect new commitments as well as the progress we have made in fulfilling our existing postmarketing commitments. Once the FDA determines a PMC is fulfilled, or they release Abbott from a commitment, or if Abbott terminates a study before completion date, those PMCs will be removed from our PMC Summary Table.

The PMCs listed in the PMC Summary Table include preclinical (nonhuman), clinical (medical), and epidemiological studies that Abbott has agreed to conduct to gather additional information about the safe and effective use of our approved products. This website does not contain technical chemistry, manufacturing and controls (CMC) PMCs, or PMCs issued by FDA for products where Abbott does not hold the US regulatory approval.

Note: All data reflects Abbott activities in 2012. Some content has been adjusted to remove data specific to AbbVie, which became a separate company on Jan. 1, 2013.


Abbott has adopted and fully embraces certain local industry codes of ethics, such as the AdvaMed Code, Medtech Code, APac Med Code, and others.  Abbott’s Code of Conduct and global compliance policies set clear ethical standards for avoiding corruption and engaging in ethical decision making.  They provide a framework for guiding interactions around the globe with anyone in a position to purchase, lease, recommend, use, arrange for the purchase or lease of, or prescribe Abbott products.


Abbott and Abbott Fund will not provide philanthropic support to organizations that discriminate on the basis of race, religion, gender, age, sexual orientation, gender identity, national origin, ethnicity, ancestry, marital status, disability, veteran status, political affiliation, HIV/AIDS status or any other legally protected status. Read more about our social impact efforts.


Abbott’s Environmental Procurement Guidelines formalizes our approach and provides guidance on incorporating sustainable sourcing principles into the purchasing process.


Read the Consent Decree document.
Read the Consent Decree amendment.